- cafead   Jan 09, 2019 at 09:22: AM
via NeuroBo Pharmaceuticals has announced its plans to initiate a phase III trial to evaluate the efficacy of its lead drug, NB-01, in diabetic neuropathic pain in early second quarter of this year.
article source
article source